PUBLISHER: The Business Research Company | PRODUCT CODE: 1947037
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947037
Radiofrequency ablation devices represent medical instruments that produce heat through medium-frequency alternating currents to ablate or eliminate abnormal tissue. These devices are employed in the destruction of cancerous tissue and the management of chronic pain by interrupting pain impulses.
The primary types of radiofrequency ablation devices include disposable equipment, reusable equipment, and capital equipment. Disposable equipment denotes medical devices designed for a single use or short duration. These are utilized in various applications, including oncology, cardiology and cardiac rhythm management, gynecology, pain management, among others, and are deployed by different end-users, such as hospitals, ambulatory surgical centers, and others.
Tariffs are impacting the radiofrequency ablation devices market by increasing costs of imported rf generators, ablation catheters, electrodes, imaging components, and electronic control units. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces export cost pressures. These tariffs are raising procedural equipment costs and influencing capital purchasing cycles. However, they are also encouraging domestic manufacturing of disposables, regional assembly of rf systems, and innovation in cost-optimized ablation platforms.
The radiofrequency ablation devices market research report is one of a series of new reports from The Business Research Company that provides radiofrequency ablation devices market statistics, including radiofrequency ablation devices industry global market size, regional shares, competitors with a radiofrequency ablation devices market share, detailed radiofrequency ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiofrequency ablation devices industry. This radiofrequency ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The radiofrequency ablation devices market size has grown rapidly in recent years. It will grow from $5.25 billion in 2025 to $5.91 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of cancer and chronic pain conditions, expansion of interventional treatment options, growing acceptance of thermal ablation therapies, availability of rf generator platforms, rising use of outpatient procedures.
The radiofrequency ablation devices market size is expected to see rapid growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing demand for image-guided oncology treatments, rising adoption of rf ablation in cardiology, expansion of ambulatory surgical procedures, growing focus on targeted pain management, increasing investment in advanced ablation technologies. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of disposable ablation catheters, growing integration of imaging-guided ablation systems, expansion of pain management applications, enhanced focus on precision tissue targeting.
Increasing chronic diseases are driving the growth of the radiofrequency ablation devices market. Chronic diseases are conditions that persist for a year or longer, requiring ongoing medical care and often limiting daily activities. Radiofrequency ablation devices are used to manage chronic and arthritic joint pain and are also employed to reduce the size of tumors, nodules, or other abnormal growths. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 35 million new cancer cases were projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the radiofrequency ablation devices market.
Major companies operating in the radiofrequency ablation devices market are focusing on introducing advanced medical devices, such as the ELIOSTAR Balloon Ablation Catheter, to strengthen their competitive position. The ELIOSTAR Balloon Ablation Catheter is designed for cardiac ablation procedures, utilizing innovative technology to treat arrhythmias and enhance precision in electrophysiological interventions. For instance, in April 2023, Compal Electronics, a Taiwan-based electronics company, launched AblatePal, a radiofrequency ablation system for percutaneous and intraoperative coagulation and ablation of soft tissue. The system uses heat generated by electrical resistance to cauterize tumors and induce necrosis, while advanced cooling technology prevents damage to surrounding healthy tissue, reduces wound size, and shortens hospital stays.
In June 2023, Avanos Medical, Inc., a US-based medical technology company, acquired Diros Technology Inc. for $53 million. Through this acquisition, Avanos aims to expand its chronic pain treatment offerings by integrating Diros's Trident RF tined probe technology with its existing COOLIEF cooled RF products, broadening its minimally invasive, non-opioid pain management portfolio. Diros Technology is a Canada-based developer of radiofrequency ablation devices.
Major companies operating in the radiofrequency ablation devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, AngioDynamics Inc, AtriCure Inc, Stryker Corporation, Smith and Nephew plc, CONMED Corporation, Hologic Inc, Olympus Corporation, BIOTRONIK SE and Co KG, Baylis Medical Company Inc, Avanos Medical Inc, Cosman Medical Inc, Lepu Medical Technology Co Ltd, RF Medical Co Ltd, Gynesonics Inc, Cutera Inc, MicroPort Scientific Corporation, Merit Medical Systems Inc, ENDO-FLEX GmbH, Bramsys Industria e Comercio Ltd
North America was the largest region in the radiofrequency ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the radiofrequency ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The radiofrequency ablation devices market consists of sales of catheters, thermopads, and hard tissue introducers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Radiofrequency Ablation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses radiofrequency ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for radiofrequency ablation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiofrequency ablation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.